Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial-Reference-Cited by-同舟云学术

Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial

Published:2015-03-30 Issue:5 Volume:13 Page:699-707
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Westenbrink B. D.¹,Alings M.²,Connolly S. J.³,Eikelboom J.³,Ezekowitz M. D.⁴,Oldgren J.⁵,Yang S.³,Pongue J.³,Yusuf S.³,Wallentin L.⁵,van Gilst W. H.¹

Affiliation:

1. Department of Cardiology; University Medical Center Groningen; Groningen The Netherlands

2. Amphia Hospital; Breda the Netherlands

3. Population Health Research Institute (PHRI); Hamilton Health Sciences and McMaster University; Hamilton ON Canada

4. Lankenau Institute for Medical Research; Wynnewood PA USA

5. Uppsala Clinical Research Center and Department of Medical Sciences; Uppsala University; Uppsala Sweden

Funder

Bayer

Boehringer-Ingelheim

Bristol-Myers Squibb

Pfizer

Abbott

Athera Biotechnologies

Regado Biosciences

Astra Zeneca

GlaxoSmithKline

Merck & Co

Sanofi Aventis

Portoloa

Boston Scientific

Daiichi Sankyo

Janssen

Eli Lilly

St Jude Medical

Sanofi

Portola

Medtronics

Aegerion

MERCK

J&J

Gilead

Janssen Scientific Affairs

Pozen Inc

AMGEN

Coherex

ARMETHEON

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12874/fullpdf

Reference34 articles.

1. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study;Go;JAMA,2001

2. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study;Benjamin;Circulation,1998

3. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis;Hart;Ann Intern Med,1999

4. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;Hart;Ann Intern Med,2007

5. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study;Apostolakis;J Am Coll Cardiol,2012

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renin‐angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry;European Journal of Internal Medicine;2024-01

2. Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study;Thrombosis Journal;2023-11-21

3. Construction of a risk scoring system using clinical factors and RYR2 polymorphisms for bleeding complications in patients on direct oral anticoagulants;Frontiers in Pharmacology;2023-11-15

4. Role of red blood cells in clinically relevant bleeding tendencies and complications;Journal of Thrombosis and Haemostasis;2023-11

5. Associations of anaemia with bleeding and thrombotic complications in patients with atrial fibrillation treated with warfarin: a registry-based nested case–control study;BMJ Open;2023-11